the MedTech Exit Blueprint - #BOSTechWeek

Thursday, May 28

8:00am – 10:00am

MTGMT

Hosted by

-‿-

ツ

Join an exclusive gathering of growth-stage MedTech founders, executive teams, and visionary investors for a targeted deep dive into the strategic landscape of medical technology acquisitions. While clinical breakthroughs are the foundation, navigating the path to a successful exit requires a strategic blueprint. This breakfast panel will deconstruct the current environment, focusing on how growth-stage companies can strategically position themselves for acquisition and the technical, clinical, and financial milestones that define a successful exit in the market. Who should attend: Growth-stage MedTech founders, executive teams, investors, and family offices. Hosted By: - One Six 8 Ventures: An operator-led venture capital fund backing the next generation of disruptive MedTech companies. https://www.onesix8ventures.com - McCarter & English: A premier law firm providing legal counsel to life science companies throughout their entire growth lifecycle. https://www.mccarter.com/ Sponsors: Bene Studio: A digital product consultancy that designs, develops, and scales robust healthtech and MedTech solutions. https://benestudio.co/ The Consulate General of Canada in Boston supports Canadian companies through trade advocacy and international business development. https://www.international.gc.ca/country-pays/us-eu/boston.aspx This event is a part of #BOSTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.

˜▾˜

*⏖*

❛ᴗ❛